UPDATE
1-AstraZeneca to pay
.52 mln to
resolve U.S. SEC
foreign bribery case
Aug 30 (Reuters) -
U.S. regulators said on Tuesday thatAstraZeneca Plc will pay
.52 million to
resolve aforeign
bribery probe into improper payments by its sales andmarketing staff to state-employed healthcare officials in Chinaand Russia.